ADIPOPHARMA
Live / Registered — Registered (as of 16 Jun 2026)
What this means for you
Registered since 16 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Jun 2032: the §71 affidavit of use).
Record
- Serial number
- 79425256
- Registration number
- 8299709
- Mark type
- Design + words
- Filed
- 01 Apr 2025
- Published for opposition
- 28 Apr 2026
- Registered
- 16 Jun 2026
- Next maintenance filing
- §71 affidavit of use, due by 16 Jun 2032 (grace period to 16 Dec 2032)
- Attorney of record
- Pina Campagna
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinary preparations for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; medications for human medicine for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for medical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; chemical preparations for pharmaceutical use for treating and preventing diabetes, insulin resistance, pancreatic, liver and kidney diseases, cardiovascular diseases, fibrosis, metabolic disorders; diagnostic preparations for medical use; cultures of microorganisms for medical use; stem cells for medical use; sanitary preparations for medical purposes; foodstuffs and dietetic food and beverages adapted for medical or veterinary use
- Class 042 — Scientific and technological services: Scientific and technological services, namely, research and design relating to drugs, pharmaceuticals, medicine; research and development services in the field of pharmacy and in particular medicines; research and development of new products for third parties; biological research; bacteriological research; chemical research; cosmetic science research; technical research in the field of new product development; scientific laboratory services; chemical analysis; material testing; technical project studies namely, conducting of feasibility studies in the field of new technologies; surveying being engineering services, engineering
Owner
- AdipoPharma, FR
- AdipoPharma, FR
- AdipoPharma, FR
Prosecution history
- 16 Sept 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Apr 2026 — PUBLISHED FOR OPPOSITION
- 23 Apr 2026 — NOTIFICATION PROCESSED BY IB
- 22 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Apr 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Apr 2026 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 27 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 Nov 2025 — REFUSAL PROCESSED BY IB